# DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity

> **NCT07075146** · PHASE3 · RECRUITING · sponsor: **José Antonio Mata Marín** · enrollment: 306 (estimated)

## Conditions studied

- HIV - Human Immunodeficiency Virus
- Obesity
- Overweight and/or Obesity

## Interventions

- **DRUG:** DOR/3TC/TDF
- **DRUG:** BIC/FTC/TAF

## Key facts

- **NCT ID:** NCT07075146
- **Lead sponsor:** José Antonio Mata Marín
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-05
- **Primary completion:** 2026-06-05
- **Final completion:** 2028-08-01
- **Target enrollment:** 306 (ESTIMATED)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07075146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07075146, "DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07075146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*